Inventory, Net of ICU MEDICAL INC/DE from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
ICU MEDICAL INC/DE quarterly Inventory, Net in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • ICU MEDICAL INC/DE Inventory, Net for the quarter ending 31 Dec 2025 was $615,859,000, a 5.3% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

ICU MEDICAL INC/DE Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $615,859,000 +$31,183,000 +5.3% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $622,443,000 -$69,595,000 -10% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $616,474,000 -$66,396,000 -9.7% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $590,326,000 -$102,680,000 -15% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $584,676,000 -$124,684,000 -18% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $692,038,000 -$67,584,000 -8.9% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $682,870,000 -$92,399,000 -12% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $693,006,000 -$54,959,000 -7.3% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $709,360,000 +$13,351,000 +1.9% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $759,622,000 +$134,354,000 +21% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $775,269,000 +$192,219,000 +33% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $747,965,000 +$211,651,000 +39% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $696,009,000 +$405,774,000 +140% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $625,268,000 +$333,667,000 +114% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $583,050,000 +$283,440,000 +95% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $536,314,000 +$236,228,000 +79% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $290,235,000 -$24,693,000 -7.8% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $291,601,000 -$30,360,000 -9.4% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $299,610,000 -$23,156,000 -7.2% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q1
Q1 2021 $300,086,000 -$11,518,000 -3.7% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $314,928,000 -$22,712,000 -6.7% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $321,961,000 -$21,754,000 -6.3% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $322,766,000 -$7,189,000 -2.2% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $311,604,000 -$10,143,000 -3.2% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $337,640,000 +$26,477,000 +8.5% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $343,715,000 +$51,875,000 +18% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $329,955,000 +$41,005,000 +14% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $321,747,000 +$26,199,000 +8.9% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $311,163,000 +$22,506,000 +7.8% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $291,840,000 -$3,708,000 -1.3% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $288,950,000 -$112,362,000 -28% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $295,548,000 -$150,136,000 -34% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $288,657,000 +$239,393,000 +486% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 $295,548,000 +$244,595,000 +480% 30 Sep 2017 10-Q 10 May 2018 2018 Q1
Q2 2017 $401,312,000 +$351,393,000 +704% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $445,684,000 +$396,444,000 +805% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 $49,264,000 +$5,632,000 +13% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 $50,953,000 +$10,272,000 +25% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $49,919,000 +$11,688,000 +31% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $49,240,000 +$11,580,000 +31% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $43,632,000 +$6,699,000 +18% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $40,681,000 +$2,433,000 +6.4% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $38,231,000 +$412,000 +1.1% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $37,660,000 +$973,000 +2.7% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $36,933,000 +$2,482,000 +7.2% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 $38,248,000 +$4,095,000 +12% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $37,819,000 +$1,538,000 +4.2% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $36,687,000 +$147,000 +0.4% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 $34,451,000 -$1,882,000 -5.2% 31 Dec 2013 10-K 20 Feb 2015 2014 FY
Q3 2013 $34,153,000 -$3,434,000 -9.1% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 $36,281,000 -$254,000 -0.7% 30 Jun 2013 10-Q 25 Jul 2013 2013 Q2
Q1 2013 $36,540,000 -$750,000 -2% 31 Mar 2013 10-Q 22 Apr 2013 2013 Q1
Q4 2012 $36,333,000 -$4,090,000 -10% 31 Dec 2012 10-K 21 Feb 2014 2013 FY
Q3 2012 $37,587,000 -$5,776,000 -13% 30 Sep 2012 10-Q 19 Oct 2012 2012 Q3
Q2 2012 $36,535,000 -$12,837,000 -26% 30 Jun 2012 10-Q 20 Jul 2012 2012 Q2
Q1 2012 $37,290,000 -$13,908,000 -27% 31 Mar 2012 10-Q 20 Apr 2012 2012 Q1
Q4 2011 $40,423,000 -$3,633,000 -8.2% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 $43,363,000 -$262,000 -0.6% 30 Sep 2011 10-Q/A 08 Dec 2011 2011 Q3
Q2 2011 $49,372,000 +$8,214,000 +20% 30 Jun 2011 10-Q/A 08 Dec 2011 2011 Q2
Q1 2011 $51,198,000 +$13,642,000 +36% 31 Mar 2011 10-Q 22 Apr 2011 2011 Q1
Q4 2010 $44,056,000 31 Dec 2010 10-K 23 Mar 2012 2011 FY
Q3 2010 $43,625,000 30 Sep 2010 10-Q 22 Oct 2010 2010 Q3
Q2 2010 $41,158,000 30 Jun 2010 10-Q 23 Jul 2010 2010 Q2
Q1 2010 $37,556,000 31 Mar 2010 10-Q 23 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.